SM

Stephen Miller

Vice President, Translational Medicine at Blueprint Medicines

Stephen Miller has over 30 years of work experience in the pharmaceutical industry. Stephen has held various leadership roles, including Vice President of Translational Medicine at Blueprint Medicines since 2014. Prior to that, they were an Executive Director of Translational Medicine at Array BioPharma. Stephen also served as Vice President of Biology at Kemia, Inc. and Director of Lead Discovery at LIGAND PHARMACEUTICALS INTERNATIONAL, INC. Stephen has also worked at Parnassus Pharmaceuticals as a Group Leader and at Amgen as a Research Scientist.

Stephen Miller has a PhD in Biochemistry from Caltech and was also a Postdoctoral Fellow in Molecular & Cellular Biology at the University of California, Berkeley.

Links

Previous companies

Amgen logo